PerkinElmer Genomics is now accepting commercial insurance for the majority of our clinical testing menu. At this time, we are considered an out-of-network laboratory for most commercial insurance plans. We continue to discuss our network status with a number of insurance plans and will provide updates as our network status(es) changes.

Our Commercial Insurance Billing Policy

  • PerkinElmer Genomics will submit an insurance claim on behalf of any patient with commercial insurance coverage. Patients are responsible for any applicable unmet deductibles, co-pays, or co-insurance set forth by their elected insurance coverage.
  • Please see our full Benefits Investigation and Out-of-Pocket Cost Policy below.
  • PerkinElmer Genomics can offer financial assistance based on the patient’s household income and household size.
  • In addition to commercial insurance billing, we offer generous Patient (Self) Payment options for patients that prefer not to submit a claim through their insurance plan.
    • To learn more about Patient Payment options, click here.
  • At this time, some of our tests are not eligible for insurance billing, including, but not limited to, all STAT testing options.

Benefit Investigation and Out-of-Pocket Cost Policy

  • PerkinElmer will contact the patient for any estimated out-of-pocket (OOP) costs that are greater than $100 USD before proceeding with testing. Testing will not start until the patient approves the estimated OOP costs. The patient’s sample will be placed on hold (for up to 30 days) until authorization to proceed is received from the patient. If the patient does not respond to PerkinElmer within 30 days to discuss estimated out-of-pocket costs, the test order may be cancelled.
    • Please note that failure by the patient to respond to PerkinElmer in a timely fashion regarding estimated out-of-pocket costs may cause a delay in the receipt of results report.
  • Any quoted OOP cost during the benefit investigation process will be honored to the patient throughout the billing process assuming there are no changes to the patient’s coverage prior to the time of billing.

Prior Authorization Information

  • Many insurance companies require a prior authorization and/or documentation of appropriate genetic counseling before genetic testing can be performed. For more details on specific pre-authorization requirements and associated forms, please click here.
  • PerkinElmer Genomics now offers the ability to facilitate the prior authorization on the physician’s behalf. This only requires a simple two-step process to complete the required documentation. Contact us today to learn more.

Medicare & Medicaid Billing Policy

  • PerkinElmer Genomics currently accepts Medicaid policies from select states across the United States. To inquire whether Medicaid is current accepted for your state, please email us at helpme@perkinelmer.com.
  • PerkinElmer Genomics does not currently accept Medicare.
  • Please contact us at helpme@perkinelmer.com with any questions.

Contact Us to Learn More

Any questions or concerns regarding billing and insurance can be submitted via helpme@perkinelmer.com or by calling 844-956-1179.

FAQS

PKIG will file an insurance claim on behalf of the patient with any commercial insurance company.

We are considered an out of network laboratory with most insurance companies. We are actively seeking in-network status and will provide updates as our status changes.
  • PerkinElmer Genomics currently accepts Medicaid policies from select states across the United States. To inquire whether Medicaid is current accepted for your state, please email us at helpme@perkinelmer.com.
  • PerkinElmer Genomics does not currently accept Medicare.
  • The Insurance Billing section on the test requisition form captures the information needed for insurance billing. This section must be completed in its entirety before testing can begin.
  • Additional information may be requested to fully process a claim, such as pertinent medical record information, and/or a letter of medical necessity.
  • PKIG can assist with a benefit investigation to determine potential insurance coverage. For assistance, please call our billing department at 1-844-956-1179 between 9 AM EST – 7 PM EST, or email helpme@perkinelmer.com
  • A benefit investigation does not guarantee coverage or payment.
  • PerkinElmer will contact the patient for any estimated out-of-pocket (OOP) costs that are greater than $100 USD before proceeding with testing. Testing will not start until the patient approves the estimated OOP costs. The patient’s sample will be placed on hold (for up to 30 days) until authorization to proceed is received from the patient. If the patient does not respond to PerkinElmer within 30 days to discuss estimated out-of-pocket costs, the test order may be cancelled. 
    • Any quoted OOP cost during the benefit investigation process will be honored to the patient throughout the billing process assuming there are no changes to the patient’s coverage prior to the time of billing.
  • A notification from PKIG will be sent to the patient once testing is complete to indicate that an insurance claim has been filed. A statement will also be mailed on a monthly basis to indicate if the insurance claim is still being processed.
  • Payment is not required until the insurance claim is fully processed and has an adjudicated outcome. At this time the monthly statement will reflect the amount due.
  • Patients are responsible for remitting to PerkinElmer Genomics any funds received directly from the insurance company.
  • Preauthorization does not guarantee payment. Exact coverage for genetic testing is determined by the details of the patient’s health insurance plan and can vary by insurance provider and employer.
  • The patient is responsible for any portion of the test fee not covered by the insurance company for any reason including, but not limited to, co-payments, co-insurance, unmet deductibles, or non-covered services.

An EOB is not a bill. An EOB is a document from your insurance company describing how your plan covers a test or service, and how much of the associated fees are paid for by your plan. An EOB will show if there is any additional amount not covered, for which you may be responsible, but is not a bill and is not necessarily the amount you will owe. The EOB typically precedes your bill. The billing statement is from PerkinElmer and will identify the out of pocket responsibility owed.

Patients have the option to pay their outstanding balance online at www.mylabbill.com or by calling our billing department at 1-844-956-1179 between 9 AM EST – 7 PM EST.

  • PerkinElmer Genomics offers two alternatives to commercial insurance billing. The first option is Institutional Billing where the ordering/provider institution is responsible for the cost of testing and an invoice is sent directly to them. The second option is Patient (Self) Pay where the patient chooses to pay directly for the test as opposed to submitting a commercial insurance claim.
  • Please note: An insurance claim cannot be submitted if Patient Pay or Institutional Billing is selected.
  • PKIG will not generate an invoice until testing is complete. We do not require a credit card to be on file, however having a credit card authorization on file allows for easy payment processing once testing is complete. PKIG accepts Visa, Mastercard, and Discover.
  • Payment can also be remitted via personal check.

PKIG’s Tax Identification Number is 25-1645804.

PKIG’s NPI Number is 18-71585067.

An order can be cancelled at any time before processing begins. However, once the sequencing process starts, tests cannot be cancelled. If you need a cancel a test, please contact our billing department at 1-866-354-2910, or email us at helpme@perkinelmer.com.